Skip to content

Novel Coronavirus (COVID-19) related learning efforts, awareness, research references

Notifications You must be signed in to change notification settings

kkm24132/COVID-19

Folders and files

NameName
Last commit message
Last commit date

Latest commit

 

History

53 Commits
 
 
 
 

Repository files navigation

COVID-19

This repository aims to cover high level view of awareness, various key sources of information that we may follow to stay us updated, some of the wiki definitions, symptoms, prevention points, vaccination information pertaining to COVID19. It also covers some of the research efforts going on in this field to gather insights, forecast predictions, novel and innovative features to understand root causes and patterns in detail. This is ongoing effort across the globe from various authorities, organizations, forums, researchers, scientists, practitioners etc. Following are the Contents of this repository (section and sub-section wise) for quick TOC to travese better.

1. Awareness

1.1 Sources

1.2 Definition

COVID-19 stands for Corona Virus Disease. It is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease was first identified in Wuhan, China in 2019.

SARS-CoV-2 Variants: Different variants and classifications around that can be explored in CDC site here. Variants of interest are as follows (please refer to CDC site for latest on this):

  • B.1.526 - First detected in US in Nov2020
  • B.1.526.1 - US in Oct2020
  • B.1.525 - UK/Nigeria in Dec2020
  • P.2 - Brazil in Apr2020
  • B.1.617 - India in Feb2021
  • B.1.617.1 - India in Dec2020
  • B.1.617.2 - India in Dec2020
  • B.1.617.3 - India in Oct2020

1.3 Symptoms

It's symptoms in humans are as follows at a high level:

Category of Symptoms Description
More Common Symptoms Fever, Dry Cough, Fatigue / Tiredness, Breathing discomfort
Less Common Symptoms Aches and Pains, Headache, Nasal Congestion, Sore throat, Diarrhoea, Conjuctivitis, Loss of taste or smell, A rash on skin etc.
Serious Symptoms High difficulty of breathing or shortness of breath, Chest pain or pressure, Loss of speech or movement

On average it takes 5–6 days from when someone is infected with the virus for symptoms to show, however it can take up to 14 days. This may change as we experience very dynamic symptoms across the globe and different waves of infections across the globe are appearing at different geographies.

1.4 Prevention Points

Protect yourself and others around you by knowing the facts and taking appropriate precautions. Follow advice provided by your local and government health authority. Some steps that can be taken for prevention efforts are as follows:

  • Clean your hands often. Use soap and water, or an alcohol-based hand rub.
  • Maintain a safe distance (ideally at least 1-meter distance) from anyone who is coughing or sneezing.
  • Cover nose and mouth when coughing & sneezing with a tissue or flexed elbow.
  • Wear a mask when physical distancing is not possible. Don’t touch your eyes, nose or mouth.
  • Stay home if you feel unwell.
  • Isolation of persons traveling from affected countries or places for at least 14 days or as directed by local/state/government authorities from time to time.
  • Quarantine if advised.
  • If you have a fever, cough and difficulty breathing, seek medical attention. Additionally, follow latest symptoms and try to protect yourself from those whenever desired.
  • It is important to keep up to date on types of symptoms as it may vary / change from time to time.
  • Here is a reference for travellers to follow TSA Guidelines for safety
  • CDC Guideline for travelers for reference

1.5 Vaccination

Name of Vaccine Description, Platform Manufacturer / WHO EUL Holder
BNT162b2/COMIRNATY Tozinameran (INN) mRNA based vaccine, Nucleoside modified mNRA Pfizer BIONTech
Moderna (mRNA-1273) mRNA based vaccine, mRNA-1273 encapsulated in lipid nanoparticle (LNP) Moderna BioTech
AstraZeneca (AZD1222) Adenovirus, Recombinant ChAdOx1 adenoviral vector encoding the Spike protein antigen of the SARS-CoV-2 AstraZeneca Oxford
Covishield (ChAdOx1_nCOV-19) Adenovirus, Recombinant ChAdOx1 adenoviral vector encoding the Spike protein antigen of the SARS-CoV-2 Serum Institute of India Pvt Ltd

Others:

  • Sputnik V - Recombinant Adenovirus vaccine (rAd26 and rAd5)
  • Janssen (JNJ-78436735; Ad26.COV2.S) - Non-replicating viral vector
  • CoronaVac - Inactivated vaccine (formalin with alum adjuvant)
  • BBIBP-CorV - Inactivated vaccine
  • EpiVacCorona - Peptide vaccine
  • Convidicea (Ad5-nCoV) - Recombinant vaccine (adenovirus type 5 vector)
  • Covaxin - Inactivated vaccine

1.6 Health and Well-being

Back to Top

2. Research and Publication efforts

2.1 References

2.2 Parameters / KPIs of risk factors for COVID

  • Hypertension
  • Diabetes
  • Respiratory diseases including COPD and chronic bronchitis
  • Heart disease
  • Cerebral infarction
  • Obesity
  • Pregnancy (evidence unclear)
  • Smoking (evidence unclear)

2.3 Datasets

Global Datasets

Back to Top

3. Solution and PoV efforts

Input data sources:

  • Thermal imaging cameras
  • CCTV camera images (both images + video clippings)
  • Thermal temperature monitoring devices and logs of those based on human wise monitoring
  • Bluetooth beacons
  • Smartphone devices with GPS enabled

Based on above data, following insights at workplace can be looked at. It can work as a Predictive Solution to alert the firm or authority.

Solution Area Capability Description Type of Input Data
Face Mask Detection Ability to indicate whether an individual is wearing face mask or not; based on video, image data analysis and share insights Image file, Video file, Text file
Occupancy Monitoring Ability to determine occupancy levels in a defined space or zone based on threshold defined by authorities. Alert authorities if it reaches threshold or goes beyond the threshold CCTV file data in Image, Video formats
No-Go Zone Monitoring and Alerting Ability to define and set certain areas as no-go zones and alert authorities when individuals are detected. Detection of humans based on near real time feed from input data sources Image file, Text file
Health Condition Monitoring Ability to monitor health data of indivuals on a periodic interval basis and provide alerts based on rules/thresholds set (biometrics and other demographics data can be taken as input based on Govt authority guidelines and to identify body vitals, stress parameters, energy level indicators for the analysis and anomaly detection) Text file
Elevated Body temperature monitoring Ability to identify elevated body temperature beyond a certain threshold set by authorities and alert accordingly Image file, Text log formats
Social Distance Measurement Monitoring and Alerting beyond defined threshold Ability to monitor distance between two co-workers in a zone to reflect zonal characterisation based on data from Smart phone devices and Bluetooth signals Text file, sensor logs

Back to Top

Contract Review related effort references

Disclaimer: The information here are for information purposes or awareness purposes. Please go to respective sites for any authenticity. These are purely my attempt for learning objectives and no way relate to any firm's opinion or any institute's opinion. Thank you and appreciate your time in visiting the repository.

About

Novel Coronavirus (COVID-19) related learning efforts, awareness, research references

Resources

Stars

Watchers

Forks

Releases

No releases published

Packages

No packages published